2R 4S-ItraconazoleAlternative Names: Isomeric itraconazole; Itraconazole - Sepracor; Itraconazole isomer
Latest Information Update: 24 Jan 2001
At a glance
- Originator Janssen L.P.
- Developer Janssen L.P.; Sepracor
- Class Antifungals
- Mechanism of Action 14-alpha demethylase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 24 Jan 2001 Discontinued-Preclinical for Mycoses in USA (Topical)
- 24 Jan 2001 Discontinued-Preclinical for Mycoses in USA (IV)
- 09 Jul 1997 New profile